SMAD5 and breast carcinoma: We demonstrate that SMAD5 expression is required to induce a CD44+/CD24-/ALDH1+ breast cancer stem cell-like phenotype, suggesting that the Aurora-A/SMAD5 axis promotes chemoresistance through activation of stemness signalling in breast cancer.